We are delighted that the great team at The Antibody Company has played such a vital role in developing a novel lateral flow device that tests for COVID-19 antibodies that is easily adaptable to mutations that arise in the virus. This important novel technology will be important in the fight against COVID-19.
De-risk promising early stage technology by using The Antibody Company's integrated research and production facilities and over 20 years' experience for developing diagnostics and therapeutics. Our Virtual Lab packages can speed up the process and save significant up-front expenditure on specialist equipment and staff.
We offer our Virtual Lab expertise for assistance and partnering in grant and commercial applications.
